drugset / Trial / NCT02442440

Anisodamine Critically Ill SeptIc Shock

NCT02442440

Phase 1/2 Completed 355 enrolled Jinhua Central Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Anisodamine has been widely used in China for its pharmacological effect on improving microcirculation during shock. It has been reported that anisodamine is effective in reducing mortality rate in children with meningitis. however, its effectiveness in patients with septic shock has not been systematically investigated. The aim of the study is to investigate the effectiveness of anisodamine in the treatment of patients with septic shock.

Timeline

Start
2015-04
Primary completion
2020-10
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Anisodamine Traditional medicine (herbal / TCM) 0.1 mg/kg
Subject Anisodamine Traditional medicine (herbal / TCM) 0.5 mg/kg